Strava Healthcare is a renowned and licensed artesunate injection manufacturer, supplier, and exporter in India and worldwide. Artesunate is the WHO first-line treatment for severe Plasmodium falciparum malaria, recommended over quinine for its faster parasite clearance and better safety profile. Our injectable formulation is purely manufactured under strict GMP conditions and is also available for institutional, government, and export procurement.
Clinical Indication
The Artesunate injection is purely there for severe malaria in adults and children where oral therapy is not feasible. It gains rapid parasite kill within 24–48 hours of administration and is compatible with both IV and IM routes.
Product Highlights
- Rapid parasite clearance — typically within 24–48 hours
- Compatible with IV and IM administration
- Suitable for paediatric and adult patients
- Available for NMCPs, hospital chains, and public health program supply
Manufacturing Quality
It is completely produced under GMP-certified conditions with full batch traceability. Each lot is completely tested for potency, sterility, particulate matter, and endotoxin limits.
Supply & Export
We supply artesunate injection to public health programs, hospital chains, and pharma distributors across India and sub-Saharan Africa. Dossier support for registration in regulated and semi-regulated markets is available on request.
Product Specifications
| Parameter | Details |
|---|---|
| Active Ingredient | Artesunate |
| Strength | 30 mg, 60 mg,120 mg, 180 mg per vial |
| Dosage Form | Powder for Injection |
| Route | IV / IM |
| Storage | Below 25°C, protect from light |
| Shelf Life | 24 months |
| Manufacturer | Strava Healthcare Private Limited |
Frequently Asked Questions
Artesunate is the WHO-recommended treatment purely for severe Plasmodium falciparum malaria, majorly used in hospital settings where the patients are unable to consume oral medication.
Yes. It is recommended for severe malaria in both adults and children. Dosing is weight-based typically ranges from 2.4 mg/kg at 0, 12, and 24 hours, then once daily.
Yes. We supply artesunate injection to government health programs, NMCPs, and tender-based procurement in India and internationally.
Yes. We provide dossier support and COPP for import registration in regulated and semi-regulated markets.